Dr. James Costello is an Associate Member in the Department of Diagnostic Imaging and Interventional Radiology at Moffitt Cancer Center. Dr. Costello earned his MD at Emory University and his PhD from Georgia Institute of Technology in Atlanta. He completed a Radiology Residency at Emory University. Dr. Costello completed a Translational Science Body MRI Research Fellowship at Emory University and also at the University of Arizona School of Medicine. Following his fellowship, he was employed at the University of Arizona as an Assistant Professor. Dr. Costello was recently at Radiology Associates of Macon, Georgia. Dr. Costello’s clinical interests focus on body imaging with an emphasis on dynamic and functional magnetic resonance imaging (MRI). Dr. Costello investigates new applications of MRI in an attempt to better quantify and describe clinical metrics. This work includes the application of MRI for assessing lobar and segmental pulmonary biomechanics, regional quantitative measurements of hepatic fibrosis, and non-invasive detection of local hypoxia using Blood Oxygenation Level Dependent (BOLD) and Tissue Oxygenation Level Dependent (TOLD) imaging.
Education & Training
University of Arizona School of Medicine - Translational Science Body MRI
CLINICAL TRIAL 20788
An Advanced MRI Abdomen Protocol to Evaluate Pancreatic Ductal Adenocarcinoma in Surgically Resectable and Borderline Resectable Disease for Loco-Regional Heterogeneity and To Evaluate Treatment Response Status Post Surgery and MRI-GRT
Condition: Gastrointestinal Tumor
Felder SI, Feuerlein S, Parsee A, Imanirad I, Sanchez J, Dessureault S, Kim R, Hoffe S, Frakes J, Costello J. Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples. Abdom Radiol (NY). 2021 May.46(5):1783-1804. Pubmedid: 33111189.
Tomaszewski MR, Dominguez-Viqueira W, Ortiz A, Shi Y, Costello JR, Enderling H, Rosenberg SA, Gillies RJ. Heterogeneity analysis of MRI T2 maps for measurement of early tumor response to radiotherapy. Nmr Biomed. 2021 Mar.34(3):e4454. Pubmedid: 33325086.
Czeyda-Pommersheim F, Martin DR, Costello JR, Kalb B. Contrast Agents for MR Imaging. Magn Reson Imaging Clin N Am. 2017 Nov.25(4):705-711. Pubmedid: 28964460.
Czeyda-Pommersheim F, Kalb B, Costello J, Liau J, Meshksar A, Arif Tiwari H, Martin D. MRI in pelvic inflammatory disease: a pictorial review. Abdom Radiol (NY). 2017 03.42(3):935-950. Pubmedid: 27933478.
Petkovska I, Duke E, Martin DR, Irani Z, Geffre CP, Cragun JM, Costello JR, Arif-Tiwari H, Czeyda-Pommersheim F, Udayasankar U, Kalb B. MRI of ovarian torsion: Correlation of imaging features with the presence of perifollicular hemorrhage and ovarian viability. Eur J Radiol. 2016 Nov.85(11):2064-2071. Pubmedid: 27776660.
Petkovska I, Martin DR, Covington MF, Urbina S, Duke E, Daye ZJ, Stolz LA, Keim SM, Costello JR, Chundru S, Arif-Tiwari H, Gilbertson-Dahdal D, Gries L, Kalb B. Accuracy of Unenhanced MR Imaging in the Detection of Acute Appendicitis: Single-Institution Clinical Performance Review. Radiology. 2016 May.279(2):451-460. Pubmedid: 26807893.
Costello JR, Kalb B, Martin DR. Incidence and Risk Factors for Gadolinium-Based Contrast Agent Immediate Reactions. Top Magn Reson Imaging. 2016 Dec.25(6):257-263. Pubmedid: 27748714.
Moinuddin I, Bracamonte E, Thajudeen B, Sussman A, Madhrira M, Costello J. Allergic Interstitial Nephritis Manifesting as a Striated Nephrogram. Case Rep Med. 2015 Dec.2015:250530. Pubmedid: 26664405. Pmcid: PMC4667022.
Costello JR, Kalb B, Chundru S, Arif H, Petkovska I, Martin DR. MR imaging of benign and malignant biliary conditions. Magn Reson Imaging Clin N Am. 2014 Aug.22(3):467-488. Pubmedid: 25086940.
Chundru S, Kalb B, Arif-Tiwari H, Sharma P, Costello J, Martin DR. MRI of diffuse liver disease: the common and uncommon etiologies. Diagn Interv Radiol. 2013 Nov.19(6):479-487. Pubmedid: 23921268.
Costello JR, Mullins ME, Votaw JR, Karolyi DR, Kalb B, Gonzales P, Fornwalt B, Meltzer CC. Establishing a new radiology residency research track. Acad Radiol. 2013 Feb.20(2):243-248. Pubmedid: 23085410.
Kalb B, Sharma P, Tigges S, Ray GL, Kitajima HD, Costello JR, Chen Z, Martin DR. MR imaging of pulmonary embolism: diagnostic accuracy of contrast-enhanced 3D MR pulmonary angiography, contrast-enhanced low-flip angle 3D GRE, and nonenhanced free-induction FISP sequences. Radiology. 2012 Apr.263(1):271-278. Pubmedid: 22438448.
Arif-Tiwari H, Kalb B, Chundru S, Sharma P, Costello J, Guessner RW, Martin DR. MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol. 20(3):209-221. Pubmedid: 24808419. Pmcid: PMC4463351.
Chundru S, Kalb B, Arif-Tiwari H, Sharma P, Costello J, Martin DR. MRI of diffuse liver disease: characteristics of acute and chronic diseases. Diagn Interv Radiol. 20(3):200-208. Pubmedid: 24808418. Pmcid: PMC4463342.
The Provider Rating is an average of all responses to specific care provider-related
questions from our nationally-recognized
Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our
Patient Satisfaction Survey . The comments are submitted by patients
and reflect their views and opinions. Patients are de-identified for confidentiality and
We post both positive and negative comments from the surveys. We do not post comments
that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may
risk the privacy of our patients.
A “[…]” in the comments below indicates de-identified patient information or comments that
are unrelated to the patient’s experience with the visit to the provider, such as
comments related to another provider, about the survey itself, or otherwise completely
Not all providers will have a star rating or comments. In order to ensure accuracy of our
ratings, we only display ratings for providers who have a minimum of 30 completed from
the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey
Patient Satisfaction Survey. If a provider does not have ratings or comments listed it
can be for several reasons, including:
The provider has not yet received the minimum number of patient satisfaction surveys
to be eligible for display. We require a minimum of 30 surveys before we post
results to ensure that the rating is statistically reliable and a true reflection of
He or she may be a researcher or other type of provider that does not see patients.
The provider practices in a specialty or office that does not use the specified
surveys currently used for these ratings.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub